000			02191 a2200589 4500
005			20250516065811.0
264		0	_c20120518
008			201205s 0 0 eng d
022			_a1873-7544
024	7		_a10.1016/j.neuroscience.2011.11.036 _2doi
040			_aNLM _beng _cNLM
100	1		_aBao, X-Q
245	0	0	_aFLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models. _h[electronic resource]
260			_bNeuroscience _cJan 2012
300			_a396-404 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdaptor Proteins, Signal Transducing
650	0	4	_aAnimals
650	0	4	_aBenzeneacetamides _xpharmacology
650	0	4	_aBlotting, Western
650	0	4	_aCell Line
650	0	4	_aChromones _xpharmacology
650	0	4	_aCorpus Striatum _xdrug effects
650	0	4	_aDNA-Binding Proteins _xbiosynthesis
650	0	4	_aDopamine _xmetabolism
650	0	4	_aDopaminergic Neurons _xdrug effects
650	0	4	_aFlow Cytometry
650	0	4	_aImmunohistochemistry
650	0	4	_aImmunoprecipitation
650	0	4	_aMPTP Poisoning _xdrug therapy
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMorpholines _xpharmacology
650	0	4	_aMovement Disorders _xdrug therapy
650	0	4	_aNeuroprotective Agents
650	0	4	_aOncogene Protein v-akt _xphysiology
650	0	4	_aPhenols _xpharmacology
650	0	4	_aPostural Balance _xdrug effects
650	0	4	_aProtein Kinase Inhibitors _xpharmacology
650	0	4	_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aTOR Serine-Threonine Kinases _xphysiology
650	0	4	_aTranscription Factors _xbiosynthesis
650	0	4	_aTyrosine 3-Monooxygenase _xmetabolism
650	0	4	_aalpha-Synuclein _xdrug effects
700	1		_aKong, X-C
700	1		_aQian, C
700	1		_aZhang, D
773	0		_tNeuroscience _gvol. 202 _gp. 396-404
856	4	0	_uhttps://doi.org/10.1016/j.neuroscience.2011.11.036 _zAvailable from publisher's website
999			_c21363341 _d21363341